Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-10

Clinical Trial Update: Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Haemorrhage Following Caesarean Section [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing carbetocin to oxytocin and ergometrine for the prevention of postpartum hemorrhage after cesarean section has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Carbetocin (carbetocin)
  • Ergometrine (ergometrine)
  • Oxytocin (Oxytocin)

Snippet

Sponsor: Beni-Suef University | Conditions: Bleeding, Anemia | Phase 4 | Status: COMPLETED